PD-1 inhibitor

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCNCT04681131BioAtla, Inc.Phase 2Completed2025-07-09Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.